Psychiatry Research
Volume 121, Issue 3 , Pages 293-301 , 1 January 2004

Lifetime and 6-month prevalence of DSM-III-R psychiatric disorders in an urban community in Japan

  • Norito Kawakami

      Affiliations

    • Hygiene and Preventive Medicine, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-86-235-7170; fax: +81-86-235-7178
    • ,
  • Hiroyuki Shimizu

      Affiliations

    • Gifu University School of Medicine, Gifu, Japan
    • ,
  • Takashi Haratani

      Affiliations

    • National Institute of Industrial Health, Kawasaki, Japan
    • ,
  • Noboru Iwata

      Affiliations

    • Division of Health Science, University of East Asia, Shimonoseki, Japan
    • ,
  • Toshinori Kitamura

      Affiliations

    • Department of Neuropsychiatry, Kumamoto University School of Medicine, Kumamoto, Japan

Received 6 June 2003 ,Revised 24 July 2003 ,Accepted 14 August 2003.

References 

  1. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilization: overview of the Australian National Mental Health Survey. British Journal of Psychiatry. 2001;178:145–153
  2. Biji R, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology. 1998;33:587–595
  3. Bland R, Orn H, Newman S. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica Supplement. 1988;338:24–32
  4. Canino GJ, Bird HR, Shrout PE, Rubio-Stipec M, Bravo M, Martinez R, et al. The prevalence of specific psychiatric disorders in Puerto Rico. Archives of General Psychiatry. 1987;44:727–735
  5. Chen C-N, Wong J, Lee N, Chan-Ho Lau J, Fung M. The Shatin Community Mental Health Survey in Hong Kong. II. Major findings. Archives of General Psychiatry. 1993;50:125–133
  6. Cross-National Collaborative Group, 1992. The changing rate of major depression. Cross-national comparisons. Journal of the American Medican Association 268, 3098–3105
  7. Faravelli C, Guerrini Degl'Innocenti B, Aiazzi L, Incerpi G, Pallanti S. Epidemiology of mood disorders: a community survey in Florence. Journal of Affective Disorders. 1990;20:135–141
  8. Helzer JE, Canino GJ, Yeh EK, Bland RC, Lee CK, Hwu HG, et al. Alcoholism—North America and Asia. A comparison of population surveys with the Diagnostic Interview Schedule. Archives of General Psychiatry. 1990;47:313–319
  9. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatrica Scandinavica. 1989;79:136–147
  10. Iwata N, Roberts CR, Kawakami N. Japan–US comparison of responses to depression scale items among adult workers. Psychiatry Research. 1995;58:237–245
  11. Joyce PR, Oakley-Browne MA, Wells JE, Bushnell JA, Hornblow AR. Birth cohort trends in major depression: increasing rates and earlier onset in New Zealand. Journal of Affective Disorders. 1990;18:83–89
  12. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatrica Scandinavica Supplement. 1998;393:6–11
  13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–19
  14. Kessler RC, Wittchen H-U, Abelson JM, McGonagle K, Schwarz N, Kendler KS, et al. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey (NCS). International Journal of Methods in Psychiatric Research. 1998;7:33–55
  15. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of American Medican Association. 2003;289:3095–3105
  16. Kitamura T, Fujihara S, Iwata N, Tomoda A, Kawakami N. Epidemiology of psychiatric disorders in Japan. In:  Nakane Y,  Radford M editor. Images in Psychiatry: Japan. Paris: World Psychiatric Association; 1999;p. 37–46
  17. Lamar J. Suicides in Japan reach a record high. British Medical Journal. 2000;321:528
  18. Lee CK, Kwak YS, Yamamoto J, Rhee H, Kim YS, Han JH, et al. Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul. Journal of Nervous and Mental Disease. 1990;178:242–246
  19. Ohmori T, Koyama T, Chen CC, Yeh EK, Reyes BV, Yamashita I. The role of aldehyde dehydrogenase isozyme variance in alcohol sensitivity, drinking habits formation and the development of alcoholism in Japan, Taiwan and the Philippines. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1986;10:229–235
  20. Simon GE, Goldberg DP, Von Korff M, Ustun TB. Understanding cross-national differences in depression prevalence. Psychological Medicine. 2002;32:585–594
  21. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association. 1996;276:293–299
  22. Weissman MM, Leaf PJ, Bruce ML, Florio L. The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. American Journal of Psychiatry. 1988;145:815–819
  23. Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce ML, et al. Affective disorders in five United States communities. Psychological Medicine. 1988;18:141–153
  24. Wells JE, Bushnell JA, Hornblow AR, Joyce PR, Oakley-Browne MA. Christchurch psychiatric epidemiology study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders. Australian and New Zealand Journal of Psychiatry. 1989;23:315–326
  25. WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bulletin of the World Health Organization 2000; 78:413–426
  26. Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. European Archives of Psychiatry and Clinical Neuroscience. 1992;241:247–258
  27. Wittchen HU, Kessler RC, Zhao S, Abelson J. Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. Journal of Psychiatric Research. 1995;29:95–110
  28. World Health Organization, 1993. Composite International Diagnostic Interview version 1.1. American Psychiatric Press, Washington, DC

PII: S0165-1781(03)00239-7

doi: 10.1016/S0165-1781(03)00239-7

Psychiatry Research
Volume 121, Issue 3 , Pages 293-301 , 1 January 2004

Article Tools